Donoghue Forlines LLC Makes New Investment in Cardinal Health, Inc. $CAH

Donoghue Forlines LLC purchased a new stake in Cardinal Health, Inc. (NYSE:CAH) during the second quarter, according to its most recent filing with the SEC. The firm purchased 17,602 shares of the company’s stock, valued at approximately $2,957,000. Cardinal Health accounts for 0.8% of Donoghue Forlines LLC’s portfolio, making the stock its 13th biggest holding.

A number of other hedge funds have also recently made changes to their positions in CAH. Counterpoint Mutual Funds LLC bought a new stake in shares of Cardinal Health in the 2nd quarter valued at about $1,911,000. Atlantic Union Bankshares Corp purchased a new stake in Cardinal Health during the second quarter valued at approximately $79,000. KLP Kapitalforvaltning AS grew its holdings in Cardinal Health by 4.0% in the second quarter. KLP Kapitalforvaltning AS now owns 114,198 shares of the company’s stock worth $19,185,000 after purchasing an additional 4,400 shares during the last quarter. Czech National Bank grew its holdings in Cardinal Health by 5.1% in the second quarter. Czech National Bank now owns 58,341 shares of the company’s stock worth $9,801,000 after purchasing an additional 2,857 shares during the last quarter. Finally, Zurich Insurance Group Ltd FI increased its position in shares of Cardinal Health by 4,935.9% during the first quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock worth $130,434,000 after purchasing an additional 927,950 shares in the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Trading Up 0.8%

CAH opened at $205.94 on Friday. Cardinal Health, Inc. has a 12-month low of $114.60 and a 12-month high of $207.47. The firm has a 50 day moving average of $164.46 and a two-hundred day moving average of $158.49. The firm has a market capitalization of $48.93 billion, a PE ratio of 31.93, a P/E/G ratio of 1.39 and a beta of 0.72.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Thursday, October 30th. The company reported $2.55 EPS for the quarter, beating the consensus estimate of $2.22 by $0.33. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business had revenue of $64.01 billion for the quarter, compared to the consensus estimate of $59.41 billion. During the same period in the prior year, the firm earned $1.88 EPS. The business’s revenue for the quarter was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be paid a dividend of $0.5107 per share. The ex-dividend date is Friday, January 2nd. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.0%. Cardinal Health’s dividend payout ratio (DPR) is presently 30.77%.

Insiders Place Their Bets

In other Cardinal Health news, insider Jessica L. Mayer sold 38,078 shares of the business’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $5,666,767.96. Following the completion of the transaction, the insider directly owned 48,457 shares of the company’s stock, valued at approximately $7,211,370.74. The trade was a 44.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Ola M. Snow sold 28,151 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total value of $4,192,809.94. Following the completion of the sale, the insider owned 15,431 shares in the company, valued at approximately $2,298,293.14. This represents a 64.59% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 271,676 shares of company stock worth $40,489,525. 0.12% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several research analysts recently weighed in on the company. Citigroup boosted their target price on Cardinal Health from $165.00 to $190.00 and gave the stock a “neutral” rating in a research note on Friday, October 31st. TD Cowen boosted their price target on Cardinal Health from $183.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, November 3rd. Wall Street Zen upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, November 8th. Argus lifted their target price on shares of Cardinal Health from $189.00 to $211.00 and gave the stock a “buy” rating in a research note on Tuesday, November 4th. Finally, Wells Fargo & Company boosted their target price on shares of Cardinal Health from $185.00 to $221.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 5th. Twelve analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $205.00.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.